Targeting Bruton's Tyrosine Kinase As a Novel Approach to Inhibit Osteoclast Function in Multiple Myeloma

被引：0
|
作者：
Eda, Homare [1 ]
Santo, Loredana [1 ]
Cirstea, Diana D. [2 ]
Pozzi, Samantha [1 ]
Canavese, Miriam [1 ]
Scullen, Tyler A. [1 ]
Vallet, Sonia [1 ]
Evans, Erica [3 ]
Singh, Juswinder [3 ]
Raje, Noopur S. [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA
[3] Avila Therapeut Inc, Bedford, MA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1243 / 1244
页数：2
相关论文
共 50 条
  • [1] Bruton's Tyrosine Kinase Targeting in Multiple Myeloma
    Von Suskil, Max
    Sultana, Kazi Nasrin
    Elbezanti, Weam Othman
    Al-Odat, Omar S.
    Chitren, Robert
    Tiwari, Amit K.
    Challagundla, Kishore B.
    Srivastava, Sandeep Kumar
    Jonnalagadda, Subash C.
    Budak-Alpdogan, Tulin
    Pandey, Manoj K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [2] Expression of Bruton's tyrosine kinase in multiple myeloma.
    Zhou, Guangbiao
    Liu, Ying
    Zhang, Bo
    Meng, Fanyi
    Liu, Xiaoli
    BLOOD, 2007, 110 (11) : 261B - 261B
  • [3] BRUTON TYROSINE KINASE EXPRESSION IN MULTIPLE MYELOMA
    Elias, L.
    Buggy, J.
    HAEMATOLOGICA, 2013, 98 : 91 - 91
  • [4] Inhibition of Bruton's tyrosine kinase as a novel therapeutic approach in multiple sclerosis
    Torke, Sebastian
    Weber, Martin S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1143 - 1150
  • [5] Bruton's tyrosine kinase: potential target in human multiple myeloma
    Liu, Ying
    Dong, Ying
    Jiang, Qian-Li
    Zhang, Bo
    Hu, An-Mei
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 177 - 181
  • [6] Bruton's tyrosine kinase: oncotarget in myeloma
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    ONCOTARGET, 2012, 3 (09) : 913 - 914
  • [7] Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
    Tai, Yu-Tzu
    Chang, Betty Y.
    Kong, Sun-Young
    Fulciniti, Mariateresa
    Yang, Guang
    Calle, Yolanda
    Hu, Yiguo
    Lin, Jianhong
    Zhao, Jian-Jun
    Cagnetta, Antonia
    Cea, Michele
    Sellitto, Michael A.
    Zhong, Mike Y.
    Wang, Qiuju
    Acharya, Chirag
    Carrasco, Daniel R.
    Buggy, Joseph J.
    Elias, Laurence
    Treon, Steven P.
    Matsui, William
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2012, 120 (09) : 1877 - 1887
  • [8] Targeting Bruton's Tyrosine Kinase in CLL
    Ahn, Inhye E.
    Brown, Jennifer R.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Lack of Bruton's tyrosine kinase results in osteoporosis, despite defects in osteoclast function
    Danks, L.
    Workman, S.
    Welaster, A. D.
    Foxwell, B. M.
    Feldman, M.
    Horwood, N. J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S255 - S255
  • [10] A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis
    Pandey, Manoj K.
    Gowda, Krishne
    Sung, Shen-shu
    Abraham, Thomas
    Budak-Alpdogan, Tulin
    Talamo, Giampolo
    Dovat, Sinisa
    Amin, Shantu
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : 31 - 42
12345